Corning Inc., National Institutes of Health, Skoll Foundation, U.S. Agency for International Development (USAID), U.S. Centers for Disease Control and Preventio

FDA established a public-private partnership to develop its CD-3 device to identify counterfeit or substandard anti-malarial medicines. In 2013-14, U.S. Pharmacopeia, with funds from USAID and the mul...